drugset / Trial / NCT03639519

A Trial to Assess the Impact of Ascorbic Acid on Cardiac Surgeries Outcomes and Complications''

NCT03639519

Phase 4 Unknown 100 enrolled El-Galaa Military Medical Complex
RandomizedParallel-groupSingle-blindTreatment

Summary

this study is evaluating the safety and efficacy of ascorbic acid as a drug that can decrease inflammatory complications post surgical in addition to its impact on decreasing risk of arrhythmia and total opioid administration post operative

Timeline

Start
2018-04-15
Primary completion
2019-04-15
Completion
2019-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 1 g Oral

Indications

No indication recorded.